NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/17/2026
Back to search
Official data from USPTO
ALLEGRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
02/17/2026
Trademark type
Combined
Nice classes
5
Filing date
12/12/2023
Registration date
02/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2026
Last transaction
02/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2024
First use in commerce
01/01/2024
Drawing code
3
Owner type
16
Owner location
Bridgewater, NJ, US
Examiner
SALTZMAN,DANIEL R
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "Allegra" with an arrow design over the last letter "a" in "Allegra".
Holders and representatives
Holders
Aventisub LLC
Representatives
Jonathan M. Rixen Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of allergic conditions and respiratory diseasesnot for ophthalmic use; nutritional supplements; food supplements for medical use.
Publications
History of USPTO decisions and trademark events.
35 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/17/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/23/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/23/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
01/20/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/20/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
01/20/2026
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
01/20/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/05/2025
GNFR
FINAL REFUSAL E-MAILED
11/05/2025
CNFR
SU - FINAL REFUSAL - WRITTEN
11/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/29/2025
ALIE
ASSIGNED TO LIE
09/29/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2025
GNRT
NON-FINAL ACTION E-MAILED
07/10/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/10/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/25/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/25/2025
IUAF
USE AMENDMENT FILED
03/25/2025
EISU
TEAS STATEMENT OF USE RECEIVED
03/25/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/19/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/19/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/19/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/15/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2024
PUBO
PUBLISHED FOR OPPOSITION
08/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/15/2024
DOCK
ASSIGNED TO EXAMINER
07/11/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/14/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/14/2024
NWAP
NEW APPLICATION ENTERED
12/12/2023
Continuous trademark protection
Get notified about every new filing that threatens ALLEGRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.